Blog
RSS FeedPosted by Michael Wonder on 11 Feb 2020
SMC approves first two ‘ultra-orphan’ pathway meds
11 February 2020 - The Scottish Medicines Consortium has released its February guidance, advising six new medicines to NHS Scotland. ...
Posted by Michael Wonder on 11 Feb 2020
SMC - February 2020 decisions
10 February 2020 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 13 Sep 2019
Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)
12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...
Posted by Michael Wonder on 08 Oct 2018
Revised process for ultra-orphan medicines
8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...
Posted by Michael Wonder on 12 Jun 2018
Cystic fibrosis patient backs campaign to make medicines available on NHS
10 June 2018 - A cystic fibrosis patient is calling for a medicine to be made available on the NHS ...